ALX Oncology Holdings (ALXO) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 16.3 | 29.0 | 60.2 | 98.4 | 141.8 | 148.7 | |||
Changes by years, y/y, % | +45% | +78% | +108% | +64% | +44% | +65.9% |
ALX Oncology Holdings. R&D, bln rub
ALX Oncology Holdings. R&D, changes, %
ALX Oncology Holdings. R&D, sum by quarters, bln rub
ALX Oncology Holdings (ALXO) R&D US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D, bln rub | 24.8 | 29.5 | 45.8 | 41.8 | 31.7 | 148.7 | ||
Changes by years, y/y, % | +45% | +10% | +56% | +66% | +28% | |||
Changes by quarters, q/q, % | -2% | +19% | +55% | -9% | -24% |